Stephanie van Hoppe

160 Chapter 6 R E F E R E N C E S T. Abe, M. Unno, T. Onogawa, T. Tokui, T.N. Kondo, R. Nakagomi, H. Adachi, K. Fujiwara, M. Okabe, T. Suzuki, K. Nunoki, E. Sato, M. Kakyo, T. Nishio, J. Sugita, N. Asano, M. Tanemoto, M. Seki, F. Date, K. Ono, Y. Kondo, K. Shiiba, M. Suzuki, H. Ohtani, T. Shimosegawa, K. Iinuma, H. Nagura, S. Ito and S. Matsuno, LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers, Gastroenterology 120 (2001), pp. 1689-1699. S.G. Aller, J. Yu, A. Ward, Y. Weng, S. Chittaboina, R. Zhuo, P.M. Harrell, Y.T. Trinh, Q. Zhang, I.L. Urbatsch and G. Chang, Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding, Science 323 (2009), pp. 1718-1722. I. Badagnani, R.A. Castro, T.R. Taylor, C.M. Brett, C.C. Huang, D. Stryke, M. Kawamoto, S.J. Johns, T.E. Ferrin, E.J. Carlson, E.G. Burchard and K.M. Giacomini, Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variants, J Pharmacol Exp Ther 318 (2006), pp. 521-529. S.D. Baker, J. Verweij, G.A. Cusatis, R.H. van Schaik, S. Marsh, S.J. Orwick, R.M. Franke, S. Hu, E.G. Schuetz, V. Lamba, W.A. Messersmith, A.C. Wolff, M.A. Carducci and A. Sparreboom, Pharmacogenetic pathway analysis of docetaxel elimination, Clin Pharmacol Ther 85 (2009), pp. 155-163. E. Bakos, R. Evers, E. Sinko, A. Varadi, P. Borst and B. Sarkadi, Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions, Mol Pharmacol 57 (2000), pp. 760-768. X. Cheng, J. Maher, C. Chen and C.D. Klaassen, Tissue distribution and ontogeny of mouse organic anion transporting polypeptides (Oatps), Drug Metab Dispos 33 (2005), pp. 1062-1073. H. Cortes-Funes and C. Coronado, Role of anthracyclines in the era of targeted therapy, Cardiovasc Toxicol 7 (2007), pp. 56-60. Y. Cui, J. Konig, A.T. Nies, M. Pfannschmidt, M. Hergt, W.W. Franke, W. Alt, R. Moll and D. Keppler, Detection of the human organic anion transporters SLC21A6 (OATP2) and SLC21A8 (OATP8) in liver and hepatocellular carcinoma, Lab Invest 83 (2003), pp. 527-538. A.J. de Graan, C.S. Lancaster, A. Obaidat, B. Hagenbuch, L. Elens, L.E. Friberg, P. de Bruijn, S. Hu, A.A. Gibson, G.H. Bruun, T.J. Corydon, T.S. Mikkelsen, A.L. Walker, G. Du, W.J. Loos, R.H. van Schaik, S.D. Baker, R.H. Mathijssen and A. Sparreboom, Influence of polymorphic OATP1B-type carriers on the disposition of docetaxel, Clin Cancer Res 18 (2012), pp. 4433-4440. M. Drozdzik, C. Groer, J. Penski, J. Lapczuk, M. Ostrowski, Y. Lai, B. Prasad, J.D. Unadkat, W. Siegmund and S. Oswald, Protein abundance of clinically relevant multidrug transporters along the entire length of the human intestine, Mol Pharm 11 (2014), pp. 3547-3555. B.J. Druker, M. Talpaz, D.J. Resta, B. Peng, E. Buchdunger, J.M. Ford, N.B. Lydon, H. Kantarjian, R. Capdeville, S. Ohno-Jones and C.L. Sawyers, Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia, N Engl J Med 344 (2001), pp. 1031-1037. S. Durmus, G. Lozano-Mena, A. van Esch, E. Wagenaar, O. van Tellingen and A.H. Schinkel, Preclinical Mouse Models To Study Human OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions in Vivo, Mol Pharm 12 (2015), pp. 4259-4269. S. Durmus, J. Naik, L. Buil, E. Wagenaar, O. van Tellingen and A.H. Schinkel, In vivo disposition of doxorubicin is affected by mouse Oatp1a/1b and human OATP1A/1B transporters, Int J Cancer 135 (2014), pp. 1700- 1710. M. Ekroos and T. Sjogren, Structural basis for ligand promiscuity in cytochrome P450 3A4, Proc Natl Acad Sci U S A 103 (2006), pp. 13682-13687. W.D. Figg, 2nd and W.D. Figg, Cabazitaxel: filling one of the gaps in the treatment of prostate cancer, Cancer Biol Ther 10 (2010), pp. 1233-1234. R.M. Franke, L.A. Scherkenbach and A. Sparreboom, Pharmacogenetics of the organic anion transporting polypeptide 1A2, Pharmacogenomics 10 (2009), pp. 339-344. B. Gao, B. Hagenbuch, G.A. Kullak-Ublick, D. Benke, A. Aguzzi and P.J. Meier, Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier, J Pharmacol Exp Ther 294 (2000), pp. 73-79. D.A. Gewirtz, A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin, Biochem Pharmacol 57 (1999), pp. 727-741.